Company DNA
Founder-Centric
About
Max Healthcare is a Large Cap company in the Healthcare sector, listed on NSE as MAXHEALTH. With a market cap of ₹101K Cr and revenue of ₹7K Cr, it is currently in the High Growth phase. Known for its Founder-Centric culture and Fast-Follower approach to innovation, the company operates at a Startup-Speed pace. Abhay Soi's active role as Chairman and MD reflects a centralized strategic vision that drives aggressive growth. Its strategic mandate: Needs transformational leadership to aggressively scale hospital bed capacity and enhance care delivery models in a consolidating healthcare market.
FAQ
What kind of company is Max Healthcare?
Max Healthcare is a Large Cap Healthcare company (MAXHEALTH) in the High Growth phase with a market cap of ₹101K Cr. It is classified as Founder-Centric in culture.
What is Max Healthcare's culture and work environment like?
Max Healthcare has a Founder-Centric culture with Fast-Follower innovation DNA and a Startup-Speed pace of execution. Employee brand: Demanding Machine. Customer relationship style: Premium-Niche. Abhay Soi's active role as Chairman and MD reflects a centralized strategic vision that drives aggressive growth.
Who leads Max Healthcare?
Max Healthcare is led by Abhay Soi (Chairman and Managing Director), a Visionary leader with 27 years of experience.
What are Max Healthcare's financials?
Max Healthcare reported revenue of ₹7K Cr in FY25 with a 5-year revenue CAGR of 21.2%. Operating margin: 22.8%. Market cap: ₹101K Cr.
Culture & Strategy
CultureFounder-Centric
InnovationFast-Follower
PaceStartup-Speed
PurposePurpose-Blended
CustomerPremium-Niche
EmployeeDemanding Machine
BrandTrusted
LifecycleHigh Growth
Abhay Soi's active role as Chairman and MD reflects a centralized strategic vision that drives aggressive growth.
Mandate
Needs transformational leadership to aggressively scale hospital bed capacity and enhance care delivery models in a consolidating healthcare market.
Needs transformational leadership to aggressively scale hospital bed capacity and enhance care delivery models in a consolidating healthcare market.
Financials
Revenue FY25₹7K Cr
PAT FY25₹1K Cr
Rev CAGR 5Y21.2%
OPM22.8%
NPM15.6%
ROE11.5%
ROCE11.8%
P/E68
Fwd P/E46.8
P/B9.6
D/E32.6
Mkt Cap₹101K Cr
Promoter26.5%
Institutional51.7%
Similar Culture
Could You Lead Max Healthcare?
Take the Genome Benchmark →